SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008636
Filing Date
2022-05-10
Accepted
2022-05-09 19:06:57
Documents
87
Period of Report
2022-04-03

Document Format Files

Seq Description Document Type Size
1 10-Q ocdx-20220403.htm   iXBRL 10-Q 2621361
2 EX-31.1 ocdx-ex31_1.htm EX-31.1 22458
3 EX-31.2 ocdx-ex31_2.htm EX-31.2 22447
4 EX-32.1 ocdx-ex32_1.htm EX-32.1 13206
5 EX-32.2 ocdx-ex32_2.htm EX-32.2 13203
  Complete submission text file 0000950170-22-008636.txt   10442787

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocdx-20220403_pre.xml EX-101.PRE 517216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocdx-20220403_cal.xml EX-101.CAL 57603
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocdx-20220403_def.xml EX-101.DEF 354550
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocdx-20220403.xsd EX-101.SCH 81564
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocdx-20220403_lab.xml EX-101.LAB 563701
81 EXTRACTED XBRL INSTANCE DOCUMENT ocdx-20220403_htm.xml XML 1877243
Mailing Address 1001 ROUTE 202 RARITAN NJ 08869
Business Address 1001 ROUTE 202 RARITAN NJ 08869 (908) 218-8000
Ortho Clinical Diagnostics Holdings plc (Filer) CIK: 0001828443 (see all company filings)

IRS No.: 981151819 | State of Incorp.: X0 | Fiscal Year End: 0102
Type: 10-Q | Act: 34 | File No.: 001-39956 | Film No.: 22906748
SIC: 2835 In Vitro & In Vivo Diagnostic Substances